Danaher Corporation (DHR)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more
What's happening with DHR?
Powered by Yahoo ScoutDanaher Corporation continues to navigate a challenging market environment, with recent collaborations enhancing its capabilities in antibody development while facing stock performance pressures against the Nasdaq. The company's Biotechnology segment shows growth, yet macroeconomic factors and internal challenges present hurdles for sustained performance.
- Previous Close
211.03 - Open
207.19 - Bid --
- Ask --
- Day's Range
205.23 - 208.70 - 52 Week Range
160.93 - 242.80 - Volume
-- - Avg. Volume
-- - Market Cap (intraday)
145.982B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
--
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
--
-
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
-
Total Cash (mrq)
--
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
